Key facts
- Notable investors include Arvo Venture Capital, Nument Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Opulproof
- ·The full record, as it builds
Funding rounds
No funding rounds for Opulproof are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Opulproof
Developer of AI research infrastructure designed to automate life sciences and academic research to accelerate the discovery and validation of novel scientific insights. The company offers a research platform featuring sentence-level citations and interactive, multi-step workflows, enabling clients to extract complex data with greater accuracy and rigor than manual human analysis.
- Sector
- Healthcare
- HQ
- Denver, CO, United States
- Founded
- 2025
- Website
- opulproof.com/
- Ownership
- Privately Held (backing)
Opulproof doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Opulproof shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Opulproof in its N-PORT filings yet. We sweep new filings monthly.